These interactions primarily involved pathways such as interleukin-17 (IL-17) and Janus kinase-signal transducer and activator of transcription (JAK-STAT), as well as various pathways related to non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene SOAT1 and metabolic dysfunction-associated steatotic liver disease.